What is the current stock price of Outset Medical, Inc. (OM)?

As of the latest market data, Outset Medical, Inc. (OM) is trading at $4.20. The stock has seen a loss of -2.78% today.

Does Outset Medical, Inc. (OM) pay a dividend?

Based on current data, Outset Medical, Inc. does not have a confirmed active dividend policy.

What is the market cap of Outset Medical, Inc.?

The current market capitalization of Outset Medical, Inc. (OM) is approximately unavailable.

OM

Outset Medical, Inc.·Healthcare

4.20

2.778%(−0.12)

Market Closed

4.56

8.571%(+0.36)

After Hours

Last Updated: — ET

52W L: $3.0052W H: $21.98

OM NEWS

globenewswire.com

2d ago

Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN JOSE, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity (the “Company”), today announced that the Compensation Committee of its Board of Directors approved equity awards under the Company's Inducement Plan, as a material inducement to employment to Derick Elliott, the Company's newly appointed Executive Vice President of Commercial, as well as one newly appointed non-executive employee, in each case, who were not previous employees or directors of the Company.

globenewswire.com

4d ago

Outset Medical Names Derick Elliott as Executive Vice President of Commercial

SAN JOSE, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today announced the appointment of Derick Elliott as Executive Vice President of Commercial, effective immediately.

defenseworld.net

Mar 16

Outset Medical, Inc. (NASDAQ:OM) Given Average Recommendation of “Moderate Buy” by Analysts

Shares of Outset Medical, Inc. (NASDAQ: OM - Get Free Report) have been given a consensus rating of "Moderate Buy" by the five research firms that are currently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, two have given a buy

globenewswire.com

Feb 24

NOTICE TO THE HOLDERS of CH1108679908, Series 6800, Open ended Valour Mantra (OM) SEK (the “Certificates”) issued by Valour Inc., LEI: 984500RAH11EE88V4014 (the “Issuer”)

ZUG, Switzerland, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Binance has announced that the Digital Asset under the Certificates will be subject to a MANTRA (OM) token swap, redenomination and rebranding to MANTRA (MANTRA): OM tokens will assume the ticker of MANTRA tokens on Binance; All OM tokens will be swapped to MANTRA at a ratio of 1 OM = 4 MANTRA though a non-dilutive split; Implementation is currently expected to take effect on 2 March 2026; and Separately, a trading halt at Spotlight regarding the Certificates is expected to be imposed on 2 March and 3 March 2026 to ensure orderly fair and market conditions. Further information regarding the token swap, redenomination and rebranding is available at: https://www.binance.com/en/support/announcement/detail/4d13052b4be943f5b155cb9150ca902c?utm_source=new_share&ref=CPA_00Q01Y04QJ The Issuer hereby gives Holders notice that said events constitute a Transformation Event as defined in the Conditions applicable to the Certificates.

defenseworld.net

Feb 19

Outset Medical, Inc. (NASDAQ:OM) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Shares of Outset Medical, Inc. (NASDAQ: OM - Get Free Report) have been given an average rating of "Moderate Buy" by the five research firms that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, two have given a buy

seekingalpha.com

Feb 11

Outset Medical, Inc. (OM) Q4 2025 Earnings Call Transcript

Company Profile

Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Sector

Healthcare

Industry

Medical - Devices

Employees

354

IPO Date

2020-09-15

Beta

1.96

Websitewww.outsetmedical.com↗